US 8796291
A3 adenosine receptor antagonists and partial agonists
granted A61PA61P11/00A61P11/02
Quick answer
US patent 8796291 (A3 adenosine receptor antagonists and partial agonists) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P11/00, A61P11/02, A61P11/06, A61P11/08